Want to see IN:ARVEE full AI Analyst Report?
ARVEE Stock Chart & Stats
₹242.32
-₹0.03(-0.02%)
At close: 4:00 PM EST
₹242.32
-₹0.03(-0.02%)
Day’s Range― - ―
52-Week Range₹129.11 - ₹290.78
Previous CloseN/A
Volume716.00
Average Volume (3M)1.40K
Market Cap
₹1.86B
Enterprise Value₹1.65K
Total Cash (Recent Filing)₹32.82M
Total Debt (Recent Filing)₹0.00
Price to Earnings (P/E)45.8
Beta1.27
Next Earnings
Nov 06, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)3.68
Shares Outstanding11,020,000
10 Day Avg. Volume2,098
30 Day Avg. Volume1,398
Financial Highlights & Ratios
PEG Ratio3.35
Price to Book (P/B)4.37
Price to Sales (P/S)4.69
P/FCF Ratio-50.88
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Very Low LeverageA lightly leveraged balance sheet reduces financial risk and interest burden, while steady equity growth provides capacity to fund operations, absorb volatility, and pursue future opportunities without relying heavily on external debt.
Positive ProfitabilityPositive operating profitability and an improved net margin indicate that the company retains an economically viable business model. This provides an earnings base that could support reinvestment if sales stability improves.
Strong Recent EPS GrowthThe substantial reported EPS increase indicates stronger earnings conversion relative to the comparison period. Although growth remains volatile, this improvement strengthens internal funding capacity and demonstrates potential for operating leverage.
Bears Say
Weak Recent Cash GenerationRecent cash absorption weakens earnings quality and may reflect working-capital swings or elevated spending needs. If sustained, negative free cash flow could limit reinvestment flexibility despite the company’s strong balance sheet.
Volatile Revenue PerformanceRepeated revenue reversals suggest unstable demand, pricing, or product mix rather than a consistent growth trajectory. Continued sales volatility can make capacity planning harder and reduce confidence in the durability of future earnings.
Margin CompressionDeclining operating margins indicate that earlier profitability levels have not been fully sustained. Persistent compression could reduce the benefit of future revenue growth and leave earnings more exposed to input costs or pricing pressure.
Arvee Laboratories (India) Ltd. News
ARVEE FAQ
What was Arvee Laboratories (India) Ltd.’s price range in the past 12 months?
Arvee Laboratories (India) Ltd. lowest stock price was ₹129.11 and its highest was ₹290.78 in the past 12 months.
What is Arvee Laboratories (India) Ltd.’s market cap?
Arvee Laboratories (India) Ltd.’s market cap is ₹1.86B.
When is Arvee Laboratories (India) Ltd.’s upcoming earnings report date?
Arvee Laboratories (India) Ltd.’s upcoming earnings report date is Nov 06, 2026 which is in 66 days.
How were Arvee Laboratories (India) Ltd.’s earnings last quarter?
Arvee Laboratories (India) Ltd. released its earnings results on Aug 07, 2026. The company reported ₹1.537 earnings per share for the quarter.
Is Arvee Laboratories (India) Ltd. overvalued?
According to Wall Street analysts Arvee Laboratories (India) Ltd.’s price is currently Overvalued.
Does Arvee Laboratories (India) Ltd. pay dividends?
Arvee Laboratories (India) Ltd. does not currently pay dividends.
What is Arvee Laboratories (India) Ltd.’s EPS estimate?
Arvee Laboratories (India) Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Arvee Laboratories (India) Ltd. have?
Arvee Laboratories (India) Ltd. has 11,020,000 shares outstanding.
What happened to Arvee Laboratories (India) Ltd.’s price movement after its last earnings report?
Arvee Laboratories (India) Ltd. reported an EPS of ₹1.537 in its last earnings report. Following the earnings report the stock price went up 0.527%.
Which hedge fund is a major shareholder of Arvee Laboratories (India) Ltd.?
Currently, no hedge funds are holding shares in IN:ARVEE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Arvee Laboratories (India) Ltd.
Arvee Laboratories (India) Ltd., established in 2012 and headquartered in Ahmedabad, India, specializes in the production and distribution of various specialized chemicals throughout the country. The company's product line includes a range of polymer modifiers, such as dimethyl 5-sodiosulfoisophthalate, 5-sulfoisophthalic acid mono sodium salt, 5-sulfoisophthalic acid mono lithium salt, and 5-sodiosulfo-bis-(ß-hydroxyethyl)-isophthalate. Additionally, Arvee Laboratories manufactures intermediates critical for contrast media, supplying compounds like 5-nitroisophthalic acid, dimethyl 5-nitroisophthalate, monomethyl 5-nitroisophthalate, 5-hydroxyisophthalic acid, 5-aminoisophthalic acid, dimethyl 5-aminoisophthalate, 3,5-dinitrobenzoic acid, and 3,5-diamino benzoic acid. The firm also provides drug intermediates, specifically 2-acetyl thiophene, thiophene-2-carboxaldehyde, 4-amino pyridine, and 2-chloro-5-nitrobenzoic acid. Beyond its domestic sales, Arvee Laboratories actively exports its chemical products.
Technical Analysis
AksharChem India Ltd.
―
Poddar Pigments Limited
―
Shankar Lal Rampal Dye-Chem Ltd.
―
Tainwala Chemicals & Plastics (India) Ltd
―
Vineet Laboratories Ltd.
―